The RIQAS Epstein Barr Virus (infectious mononucleosis) EQA programme is designed to monitor the performance of tests used to detect EBV virus antibodies. All samples are conveniently supplied liquid ready-to-use and are suitable for both quantitative and qualitative methods of analysis.
- Liquid ready-to-use
- 100% human Plasma
- Quarterly reporting (3 samples per quarterly distribution)
- Submit results and view reports online via RIQAS.Net
- Suitable for both quantitative and qualitative methods of analysis
Not accredited to ISO/IEC 17043
- Anti-EBNA IgG
- Anti-EBV VCA IgG
- Anti-EBV VCA IgM
Please note, product availability may vary country to country.